VAXX News and Press, Vaxxinity Inc. From 03/28/23

Vaxxinity CEO Mei Mei Hu to participate in fireside chat with Sarah Despres, Counselor to the Secretary for Public Health and Science, U.S. Department of Health and Human Services, at World Vaccine Congress UB-313 to be Featured in Emerging Science Presentation at AAN Annual Meeting ...

2023-03-27 09:28:16 ET Vaxxinity press release ( NASDAQ: VAXX ): Q4 GAAP EPS of -$0.16 in-line. As of December 31, 2022, Vaxxinity had $87.9 million of highly liquid assets, including $33.5 million of cash and cash equivalents, $53.4 million of short-term investment...

CAPE CANAVERAL, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the fourth quarter and full year ended December 31, 2022. “We are...

CAPE CANAVERAL, Fla., March 21, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, announced today that it has joined TransCelerate BioPharma, Inc. (TransCelerate) as the first emerging biot...

CAPE CANAVERAL, Fla., March 20, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that the first subjects have been dosed in a randomized, double-blind, placebo-controlled Phase 1 c...

CAPE CANAVERAL, Fla., March 02, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that its scientists and executives will present at three upcoming scientific and medical conference...

Appointment of new directors bring diversity, balance and relevant industry expertise to Vaxxinity Establishment of Frontier Exploration Laboratories (“VaxxLabs”) in Cape Canaveral, Fla., as corporate headquarters CAPE CANAVERAL, Fla., Feb. 01, 2023 (GLOBE NEWSWIRE) ...

Vaxxinity ( NASDAQ: VAXX ) shareholders have a lot to cheer about so far in 2023 as the stock is up 158% year to date. On Monday alone, shares are up 23% . Monday marks the 14th straight trading session of gains. Volume is extremely heavy so far Monday. Average daily v...

Shares of clinical-stage biotech company Vaxxinity (NASDAQ: VAXX) were up 28.2% for the week as of Thursday afternoon, according to data provided by S&P Global Market Intelligence . The stock closed at $2.02 a share last week and rose to as high as $2.63 on Thursday. The stock...

Summary We may not be at the end credits for COVID-19 virus. Shares of Vaxxinity, Inc., like most biotechs, have plummeted over the past year due to unprecedented market headwinds, both macroeconomic and geopolitical. In the meantime, the company has been taking care of its COVID-19...